Yesterday, the Green Ribbon Panel issued a statement emphasizing the importance of Canada-US economic cooperation to secure a sustainable energy future and strengthen ...

Avec Les Echos suivez en temps réel toute l'actualité financière puisée aux meilleures sources des sociétés cotées.

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs ...

In the medical device industry, FDA inspections are not a regulatory hurdle — they are a powerful tool for improving product ...

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

From turning away inspectors to falsifying data and leaving "bare footprints" in production containers, two of the latest ...

Mumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration ...

Piramal Pharma slipped 1.14% to Rs 195.40 after the US FDA issued a Form-483 with 6 observations to the company's Turbhe facility post a GMP inspection.

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

Shares of firms like Vedanta, Tata Steel, RVNL, Max Healthcare, Allcargo Gati, and others will be in focus on Wednesday's ...

The observations are mainly procedural and do not indicate any data integrity issues, Piramal Pharma added in a regulatory ...